SG11202012378SA - Composition containing a somatostatin analogue for radiopharmaceutical use - Google Patents
Composition containing a somatostatin analogue for radiopharmaceutical useInfo
- Publication number
- SG11202012378SA SG11202012378SA SG11202012378SA SG11202012378SA SG11202012378SA SG 11202012378S A SG11202012378S A SG 11202012378SA SG 11202012378S A SG11202012378S A SG 11202012378SA SG 11202012378S A SG11202012378S A SG 11202012378SA SG 11202012378S A SG11202012378S A SG 11202012378SA
- Authority
- SG
- Singapore
- Prior art keywords
- composition containing
- somatostatin analogue
- radiopharmaceutical use
- radiopharmaceutical
- somatostatin
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/083—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins the peptide being octreotide or a somatostatin-receptor-binding peptide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
- A61K51/121—Solutions, i.e. homogeneous liquid formulation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
- A61K51/1241—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2123/00—Preparations for testing in vivo
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Optics & Photonics (AREA)
- Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dispersion Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP18179052 | 2018-06-21 | ||
PCT/EP2019/066329 WO2019243489A1 (en) | 2018-06-21 | 2019-06-20 | Composition containing a somatostatin analogue for radiopharmaceutical use |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11202012378SA true SG11202012378SA (en) | 2021-01-28 |
Family
ID=62748818
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11202012378SA SG11202012378SA (en) | 2018-06-21 | 2019-06-20 | Composition containing a somatostatin analogue for radiopharmaceutical use |
Country Status (12)
Country | Link |
---|---|
US (1) | US11969484B2 (en) |
EP (1) | EP3810209A1 (en) |
JP (2) | JP7482792B2 (en) |
KR (1) | KR20210024017A (en) |
CN (1) | CN112312933A (en) |
AU (1) | AU2019289886A1 (en) |
CA (1) | CA3103190A1 (en) |
EA (1) | EA202190096A1 (en) |
IL (1) | IL279478A (en) |
SG (1) | SG11202012378SA (en) |
TW (1) | TW202015744A (en) |
WO (1) | WO2019243489A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN117580595A (en) * | 2021-06-29 | 2024-02-20 | 生命分子影像有限公司 | Novel kit for radiolabelled chelator functionalized targeted conjugate radiopharmaceutical formulations |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9417873D0 (en) * | 1994-09-06 | 1994-10-26 | Sandoz Ltd | Organic compounds |
BRPI0717135B8 (en) * | 2006-10-16 | 2021-05-25 | Salk Inst Biological Studies | cyclic somatostatin peptide antagonist and pharmaceutical composition |
US8691761B2 (en) * | 2006-10-16 | 2014-04-08 | Jean E. F. Rivier | Somatostatin receptor 2 antagonists |
EP3015462A1 (en) * | 2014-10-29 | 2016-05-04 | OctreoPharm Schiences GmbH | Enantiopure chelating agents for chelator coupled pharmaceuticals, corresponding preparation method thereof and chelator coupled pharmaceuticals |
CA2965665A1 (en) | 2014-11-12 | 2016-05-19 | Immunomedics, Inc. | Methods and compositions for improved labeling of targeting peptides |
GB201504064D0 (en) * | 2015-03-10 | 2015-04-22 | Accretion Biotechnology Ltd | Method and kits for preparing radionuclide complexes |
WO2018065634A1 (en) * | 2016-10-07 | 2018-04-12 | Cyprumed Gmbh | Pharmaceutical compositions for the nasal delivery of peptide or protein drugs |
-
2019
- 2019-06-13 TW TW108120442A patent/TW202015744A/en unknown
- 2019-06-20 JP JP2020570841A patent/JP7482792B2/en active Active
- 2019-06-20 WO PCT/EP2019/066329 patent/WO2019243489A1/en unknown
- 2019-06-20 CN CN201980040633.6A patent/CN112312933A/en active Pending
- 2019-06-20 SG SG11202012378SA patent/SG11202012378SA/en unknown
- 2019-06-20 US US17/251,426 patent/US11969484B2/en active Active
- 2019-06-20 KR KR1020217001533A patent/KR20210024017A/en unknown
- 2019-06-20 EP EP19730841.4A patent/EP3810209A1/en active Pending
- 2019-06-20 CA CA3103190A patent/CA3103190A1/en active Pending
- 2019-06-20 EA EA202190096A patent/EA202190096A1/en unknown
- 2019-06-20 AU AU2019289886A patent/AU2019289886A1/en active Pending
-
2020
- 2020-12-16 IL IL279478A patent/IL279478A/en unknown
-
2023
- 2023-12-28 JP JP2023222257A patent/JP2024045148A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
EP3810209A1 (en) | 2021-04-28 |
US11969484B2 (en) | 2024-04-30 |
WO2019243489A1 (en) | 2019-12-26 |
EA202190096A1 (en) | 2021-03-22 |
US20230181771A1 (en) | 2023-06-15 |
KR20210024017A (en) | 2021-03-04 |
JP7482792B2 (en) | 2024-05-14 |
AU2019289886A1 (en) | 2021-01-21 |
CA3103190A1 (en) | 2019-12-26 |
TW202015744A (en) | 2020-05-01 |
CN112312933A (en) | 2021-02-02 |
IL279478A (en) | 2021-01-31 |
JP2021527681A (en) | 2021-10-14 |
JP2024045148A (en) | 2024-04-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2608525B (en) | A resin composition | |
IL283692A (en) | Novel composition | |
IL283445A (en) | Jettable composition | |
SG11202012734YA (en) | Composition | |
EP3586814A4 (en) | Curable composition for dental use | |
GB201818164D0 (en) | New composition | |
EP3824011C0 (en) | A coating composition | |
IL289619A (en) | Pharmaceutical composition comprising a tetrahydropyrazolopyrimidinone compound | |
ZA202103144B (en) | Non-aluminium antiperspirant compositions | |
ZA202103148B (en) | Non-aluminium antiperspirant compositions | |
GB201804434D0 (en) | Composition | |
EP3877437C0 (en) | A coating composition | |
PT3827036T (en) | Composition for a structural adhesive | |
IL279478A (en) | Composition containing a somatostatin analogue for radiopharmaceutical use | |
CA192771S (en) | Four-sided pen | |
SG11202012324QA (en) | A bone cement composition | |
IL279481A (en) | Composition containing a somatostatin analogue for radiopharmaceutical use | |
CA192770S (en) | Four-sided pen | |
EP3836905C0 (en) | Novel oral composition | |
SG11202012307VA (en) | Resin composition for cleaning use | |
GB201917899D0 (en) | New composition | |
GB201811061D0 (en) | Novel composition | |
GB201918274D0 (en) | A composition | |
GB2561723B (en) | A composition for oral administration | |
ZA201905132B (en) | Pharmaceutical composition comprising a somatostatin peptide analogue |